Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fouremm

Rank: President [?]

Points: 3253 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - High Level Summary

in response to

Re: AGM - High Level Summary

Toinv

posted on Jan 12, 2016 05:38PM

Toinv that is correct, Don said that after Brad Cann has done his accounting wizardry that all shareholders of ZCC would have the same number of shares in the new operating company.

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply